Robert Eggertsen

1.8k total citations
81 papers, 1.4k citations indexed

About

Robert Eggertsen is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Robert Eggertsen has authored 81 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 23 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Surgery. Recurrent topics in Robert Eggertsen's work include Blood Pressure and Hypertension Studies (18 papers), Thyroid Disorders and Treatments (13 papers) and Thyroid Cancer Diagnosis and Treatment (8 papers). Robert Eggertsen is often cited by papers focused on Blood Pressure and Hypertension Studies (18 papers), Thyroid Disorders and Treatments (13 papers) and Thyroid Cancer Diagnosis and Treatment (8 papers). Robert Eggertsen collaborates with scholars based in Sweden, Qatar and Malta. Robert Eggertsen's co-authors include Lennart Andrén, L. Hansson, Lennart Hansson, Ernst Nyström, Ramon Sivertsson, Helena Filipsson Nyström, Lena Hulthén, G Lindstedt, Maria E. H. Larsson and Dan Mellström and has published in prestigious journals such as Diabetes Care, The American Journal of Medicine and European Heart Journal.

In The Last Decade

Robert Eggertsen

80 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Eggertsen Sweden 22 456 310 188 145 142 81 1.4k
Ahuva Golik Israel 24 218 0.5× 485 1.6× 224 1.2× 141 1.0× 192 1.4× 92 1.8k
R. W. Newton United Kingdom 20 925 2.0× 185 0.6× 259 1.4× 141 1.0× 81 0.6× 40 1.7k
S. V. Madhu India 22 498 1.1× 241 0.8× 149 0.8× 59 0.4× 92 0.6× 78 1.4k
Elaine Chiquette United States 18 326 0.7× 532 1.7× 195 1.0× 60 0.4× 329 2.3× 38 1.8k
Emaad M. Abdel‐Rahman United States 22 198 0.4× 224 0.7× 180 1.0× 61 0.4× 67 0.5× 73 1.4k
Karin Manhem Sweden 25 341 0.7× 778 2.5× 162 0.9× 72 0.5× 114 0.8× 77 1.6k
John V. St. Peter United States 20 285 0.6× 252 0.8× 219 1.2× 95 0.7× 230 1.6× 59 1.8k
Lynda Booker Canada 15 521 1.1× 232 0.7× 110 0.6× 55 0.4× 265 1.9× 25 1.8k
Sue Penckofer United States 25 484 1.1× 255 0.8× 182 1.0× 97 0.7× 74 0.5× 58 1.9k
H Åberg Sweden 22 208 0.5× 407 1.3× 242 1.3× 102 0.7× 132 0.9× 87 1.7k

Countries citing papers authored by Robert Eggertsen

Since Specialization
Citations

This map shows the geographic impact of Robert Eggertsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Eggertsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Eggertsen more than expected).

Fields of papers citing papers by Robert Eggertsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Eggertsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Eggertsen. The network helps show where Robert Eggertsen may publish in the future.

Co-authorship network of co-authors of Robert Eggertsen

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Eggertsen. A scholar is included among the top collaborators of Robert Eggertsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Eggertsen. Robert Eggertsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eggertsen, Robert, et al.. (2024). Effects of beetroot juice on blood pressure in hypertension according to European Society of Hypertension Guidelines: A systematic review and meta-analysis. Nutrition Metabolism and Cardiovascular Diseases. 34(10). 2240–2256. 6 indexed citations
2.
Eggertsen, Robert, et al.. (2021). A randomized, double-blind study of iodine supplementation during pregnancy in Sweden: pilot evaluation of maternal iodine status and thyroid function. European Journal of Nutrition. 60(6). 3411–3422. 17 indexed citations
3.
Henriksson, Malin, Alexander Wall, Jenny Nyberg, et al.. (2021). Effects of exercise on symptoms of anxiety in primary care patients: A randomized controlled trial. Journal of Affective Disorders. 297. 26–34. 53 indexed citations
4.
Nyberg, Jenny, Malin Henriksson, Alexander Wall, et al.. (2021). Anxiety severity and cognitive function in primary care patients with anxiety disorder: a cross-sectional study. BMC Psychiatry. 21(1). 617–617. 20 indexed citations
5.
Larsson, Maria E. H., et al.. (2019). Health effects of direct triaging to physiotherapists in primary care for patients with musculoskeletal disorders: a pragmatic randomized controlled trial. Therapeutic Advances in Musculoskeletal Disease. 11. 1759720X19827504–1759720X19827504. 40 indexed citations
6.
7.
Andersson, Maria, et al.. (2019). Iodine deficiency in pregnant women in Sweden: a national cross-sectional study. European Journal of Nutrition. 59(6). 2535–2545. 31 indexed citations
8.
Larsson, Christel, Caroline Mellberg, Bernt Lindahl, et al.. (2017). A Paleolithic-type diet results in iodine deficiency: a 2-year randomized trial in postmenopausal obese women. European Journal of Clinical Nutrition. 72(1). 124–129. 30 indexed citations
9.
Sigurjónsdóttir, Helga Ágústa, Ove Andersson, Robert Eggertsen, et al.. (2012). Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC Endocrine Disorders. 12(1). 17–17. 25 indexed citations
10.
Hjerpe, Per, et al.. (2010). Variation in plasma calcium analysis in primary care in Sweden - a multilevel analysis. BMC Family Practice. 11(1). 43–43. 9 indexed citations
11.
Nyström, Helena Filipsson, Maria Andersson, Robert Eggertsen, et al.. (2010). Thyroid volume in Swedish school children: a national, stratified, population-based survey. European Journal of Clinical Nutrition. 64(11). 1289–1295. 30 indexed citations
12.
Eggertsen, Robert, et al.. (2007). Effects of treatment with a commercially available St John's Wort product (Movina®) on cholesterol levels in patients with hypercholesterolemia treated with simvastatin. Scandinavian Journal of Primary Health Care. 25(3). 154–159. 21 indexed citations
13.
Andrén, Lennart, et al.. (2007). Interaction between a commercially available St. John’s wort product (Movina) and atorvastatin in patients with hypercholesterolemia. European Journal of Clinical Pharmacology. 63(10). 913–916. 47 indexed citations
14.
Mellström, Dan, et al.. (2005). Osteoporosis in a nursing home, determined by the DEXA technique.. PubMed. 11(2). CR67–70. 15 indexed citations
15.
Berg, Gertrud E. B., et al.. (2005). Effect of lifelong iodine supplementation on thyroid 131-I uptake: a decrease in uptake in euthyroid but not hyperthyroid individuals compared to observations 50 years ago. European Journal of Clinical Nutrition. 60(2). 210–213. 13 indexed citations
16.
Berg, Gertrud E. B., et al.. (2004). Urinary iodine and thyroid volume in a Swedish population. Journal of Internal Medicine. 255(5). 610–614. 18 indexed citations
17.
Eggertsen, Robert, et al.. (1993). The value of screening for retinopathy and microalbuminuria in patients with type 2 diabetes in primary health care. Scandinavian Journal of Primary Health Care. 11(2). 135–140. 14 indexed citations
18.
Eggertsen, Robert, Karen L. Petersen, P A Lundberg, Erin M. Nystrom, & G Lindstedt. (1988). Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit.. BMJ. 297(6663). 1586–1592. 80 indexed citations
19.
Dahlöf, Björn, Robert Eggertsen, & Lennart Hansson. (1988). Calcium Antagonists Combined with β-Blockers or ACE Inhibitors in the Treatment of Hypertension. Journal of Cardiovascular Pharmacology. 12(Supplement 6). S104–S108. 20 indexed citations
20.
Dahlöf, Björn, Lennart Andrén, Robert Eggertsen, et al.. (1987). Addition of the Calcium Antagonist PN 200–110 to Pindolol Markedly Augments the Antihypertensive Effect in Essential Hypertension. Journal of Cardiovascular Pharmacology. 10. S102–104. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahuva Golik Breakdown of academic impact, for papers by R. W. Newton Breakdown of academic impact, for papers by S. V. Madhu Breakdown of academic impact, for papers by Elaine Chiquette Breakdown of academic impact, for papers by Emaad M. Abdel‐Rahman Breakdown of academic impact, for papers by Karin Manhem Breakdown of academic impact, for papers by John V. St. Peter Breakdown of academic impact, for papers by Lynda Booker Breakdown of academic impact, for papers by Sue Penckofer Breakdown of academic impact, for papers by H Åberg
Rankless by CCL
2026